1[1]Bergman RN, Finegood DT, Ader M, et al. Assessment of insulin sensitivity in vivo. Endocri Rew 1985;6(1) :45
2[2]Welch S, Gebhart P, Bernman RN, et al. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 1990;71(6):1509
3[3]Coates PA, Ollerton RL, Luzio, et al. Reduced sampling protocols in estimation of insulin sensitivity and glucose effectiveness using the minimal model in NIDDM. Diabetes 1993;42:1635
4[4]Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37:1595
5[5]Reaven GM. Insulin resistance, hyperinsulinemia, hypertriglyceridemia and hypertension, paralles between human disease and rodent males. Diabetes Care 1991;14:195
6[6]Steiner DF, Ohagi S, Bell GI, et al. Is islet amyloid polypeptide a significant factor in pathogenesis or pathophysiology of diabetes? Diabetes 1991 ;40(3) :305
7[7]Rssetti L, Giaccari A, DeFronzo RA, et al. Glucose toxicity. Diabetes Care 1990; 13(6) :610
8[8]Lindstedt G, Lunberg PA, Lapidus L, et al. Low sex-hormonebinding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow up of population study of women in Goyherburg, Sweden. Diabetes 1991 ;40( 1 ): 123
9[9]Lindheim SR, Presser SC, Ditkoff W, et al. A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. Fertil Steril 1993;60(4) :664
10[10]Preziosi P, Barrett-Connor E, Papoz L, et al. Interrelation between sex hormone-binding globulin and plasma insulin inhealthy adult women:the telecom study. J Clin Endocrinol Metab 1993;76(2) :383
